DKSH has signed a strategic partnership agreement with Trautec, a Chinese manufacturer of recombinant human collagen (SRHC) technology for skincare and haircare, covering Canada and the USA.
The Swiss-based distributor will provide business development, marketing, sales, logistics, and distribution services for Trautec’s trademarked SRHC ingredients, including ReCol3, ReCol17, MiniReCol3, and MiniReCol17.
These ingredients offer remarkable stability and efficacy in addressing various skincare solutions, such as anti-ageing, wrinkle reduction, UV damage mitigation, anti-inflammation, as well as promoting hair density and scalp repair.
SRHC offers an animal-free recombinant collagen derived from eukaryotic yeast using advanced bio-engineering techniques.
SRHC achieves 100% homology and biocompatibility through a multi-step purification process, ensuring optimal active sites and high stability that emulate human collagen. This innovative approach eliminates potential risks and biosafety concerns associated with collagens sourced from animals.
Song Qian, CEO and Founder, Trautec, said: “SRHC is increasingly popular in the cosmetic and regenerative medicine sectors, offering vast opportunities for innovative solutions across a wide range of consumer products.
“We are excited to have DKSH on board for this journey, as their considerable experience, knowledge, and global network in the beauty and personal care market will help us enter an exhilarating growth phase.”
